FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Aptus Pharma LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:544529 P/E (TTM) :0
ISIN Demat:INE15XJ01010 Div & Yield %:0 EPS (TTM) :0
Book Value (RS) :29.1342566 Market Cap (Rs Cr.):109.76 Face Value (RS) :10
    Change Company 
YearsMar 2025Mar 2024
Debt-Equity Ratio1.792.74
Long Term Debt-Equity Ratio0.752.18
Current Ratio1.741.94
Fixed Assets15.8516.61
Inventory4.686.23
Debtors5.466.21
Interest Cover Ratio9.945.67
PBIDTM (%)20.078.79
PBITM (%)18.977.61
PBDTM (%)18.167.45
CPM (%)13.725.66
APATM (%)12.624.48
ROCE (%)37.6325.83
RONW (%)70.9458.39

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)